Rezultati - Simone Gastaldi

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation

    A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation od Carolina Pellegrini, Matteo Fornai, Rocchina Colucci, Laura Benvenuti, Vanessa D’Antongiovanni, Gianfranco Natale, Federica Fulceri, Marta Giorgis, Elisabetta Marini, Simone Gastaldi, Massimo Bertinaria, Corrado Blandizzi, Luca Antonioli

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer

    Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer od Simone Gastaldi, Francesco Sassi, Paolo Accornero, Davide Torti, Francesco Galimi, Giorgia Migliardi, Gemma Molyneux, Timothy Perera, Paolo M. Comoglio, Carla Boccaccio, Matthew J. Smalley, Andrea Bertotti, Livio Trusolino

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury

    Novel NLRP3 inhibitor INF195: Low doses provide effective protection against myocardial ischemia/reperfusion injury od Simone Gastaldi, Magalì Giordano, Federica Blua, Chiara Rubeo, Valentina Boscaro, Saveria Femminò, Stefano Comità, Eleonora Gianquinto, Vanessa Landolfi, Elisabetta Marini, Margherita Gallicchio, Francesca Spyrakis, Pasquale Pagliaro, Massimo Bertinaria, Cláudia Penna

    Izdano 2024
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation

    Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced... od Simone Gastaldi, Carmine Rocca, Eleonora Gianquinto, Maria Concetta Granieri, Valentina Boscaro, Federica Blua, Barbara Rolando, Elisabetta Marini, Margherita Gallicchio, Anna De Bartolo, Naomi Romeo, Rosa Mazza, Francesco Fedele, Pasquale Pagliaro, Cláudia Penna, Francesca Spyrakis, Massimo Bertinaria, Tommaso Angelone

    Izdano 2023
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: